Outcome of the Board meeting dated 25.08.2026

Date: August 25, 2026 The General Manager DCS - CRD BSE LIMITED Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Scrip code: 524336 Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board at its meeting held on Tuesday, August 25, 2026 inter-alia approved the following: 1. Issue of 22,85,000 Convertible Warrants of Rs. 176.10/- each at par, aggregating to Rs. 40,23,88,500/- on preferential basis convertible into equal number of equity shares, subject to the approval of shareholders of the Company. 2. Re-appointment of Shri Bankesh Chandra Agrawal (DIN: 00121080) as Chairman & Managing Director of the Company for a further period of three years with effect from November 11, 2026 and payment of remuneration to him, subject to the approval of shareholders of the Company. 3. Re-appointment of Shri Sarthak Agarwal (DIN: 03613314) as Whole Time Director of the Company for a further period of three years with effect from November 11, 2026 and payment of remuneration to him, subject to the approval of shareholders of the Company. 4. Re-appointment of Shri Nihit Agarwal(DIN: 07586882) as Whole Time Director of the Company for a further period of three years with effect from November 11, 2026 and payment of remuneration to him, subject to the approval of shareholders of the Company. 5. Re-appointment of Mr. Shri Ram Gupta (DIN: 07028932) as Independent Director of the Company for a second term of five years with effect from September 29, 2026, subject to the approval of shareholders of the Company. 6. Appointment of Shri Amrut Urkude (DIN: 11902244) as an Additional Independent Director of the Company for a period of five years with effect from August 25, 2026, subject to the approval of shareholders of the Company. 7. Alteration of Object Clause of the Memorandum of Association of the Company, subject to the approval of shareholders of the Company. 8. Convening of 39th Annual General Meeting of the Company on Thursday, September 24, 2026. 9. Appointment of Mr. Shri Ram Gupta (DIN: 07028932) as an Additional Independent Director (Non- Executive) on the Board of Shakambhari Dyechem Private Limited, material subsidiary of the Company. 10. Expansion/set-up in existing and new unit for Dye & Dye Intermediates and/or other organic and in-organic chemicals. The details as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026, shall be intimated upon the receipt of the requisite approvals and commencement of the implementation process. 11. Investment in the wholly-owned subsidiary, Shakambhari Dyechem Private Limited for funding its capital expenditure requirements including working capital for proposed expansion and allied activities. The details as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026, shall be intimated upon the receipt of the requisite approvals and upon actual investments. The information as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/49/14/14(7)2025- CFD-POD2/I/3762/2026 dated January 30, 2026 for the issue of Convertible Warrants and Appointment/Reappointment of Directors and amendments to Memorandum of Association of Company is enclosed. The Meeting commenced at 12.15 p.m. and concluded at 6.00 p.m. Thanking you. Yours faithfully, FOR SHREE HARI CHEMICALS EXPORT LIMITED B.C. AGRAWAL Chairman & Managing Director DIN: 00121080 DETAILS PURSUANT TO REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015, READ WITH SEBI CIRCULAR NO. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 DATED 30th JANUARY 2026 Sr. Particulars a) Type of securities Convertible Warrants convertible into equal number of Equity proposed to be issued Shares. (viz. equity shares, convertibles etc.) b) Type of issuance Preferential Issue in accordance with the provisions of the (further public Companies Act, 2013 and the rules made thereunder and SEBI offering, rights issue, (Issue of Capital and Disclosure Requirements) Regulations, 2018, depository receipts as amended ("ICDR Regulations") and other applicable laws. (ADR/GDR), qualified institutions placement, preferential allotment etc.); c) Total number of Issue of 22,85,000 (Twenty Two Lakhs Eighty Five Thousand) securities proposed to Convertible Warrants of Rs. 176.10/- each at par, aggregating to be issued or the total Rs. 40,23,88,500/- on a preferential basis to the following amount for which the promoters, convertible into 22,85,000 Equity Shares of face value of securities will be Rs. 10/- each at a premium of Rs. 166.10/- per share: issued (approximately); Sr. Name of the Allottees No. of Convertible No Warrants proposed to be issued 1. Shri Nihit Agarwal 6,85,500 2. Smt. Priyamvada Agarwal 6,85,500 3. Smt. Avanticka Agarwal 4,57,000 4. Smt. Smradhi Agarwal 4,57,000 The Convertible Warrants shall be converted into equity shares in one or more tranches within a period of eighteen months from the date of the allotment. d) In case of preferential issue the listed entity shall disclose the following additional details to the stock exchange(s): i. names of the investors; Sr. Name of the Investors Category 1. Shri Nihit Agarwal Promoter 2. Smt. Priyamvada Agarwal 3. Smt. Avanticka Agarwal 4. Smt. Smradhi Agarwal ii. post allotment of Post allotment of securities: securities - outcome of the subscription, issue Sr. Name of the Pre-issue No. ofShareholding price / allotted price No Proposed shareholding Warrants post (in case of allottee to be conversion of convertibles), number issued Warrants* of investors; No. % of No. % of of shares of shares equity equity shares shares held held 1. Shri Nihit 3000 0.05 6,85,500 6,88,500 8.01 Agarwal 2. Smt. 13,784 0.22 6,85,500 6,99,284 8.13 Priyamvada Agarwal 3. Smt. Avanticka 4,107 0.07 4,57,000 4,61,107 5.36 Agarwal 4. Smt. Smradhi 37,000 0.59 4,57,000 4,94,000 5.75 Agarwal *Note: The table shows the expected shareholding pattern of the Company upon assumption on that entire Convertible Warrants issued will be converted in one or more tranches into Equity shares of the Company within a period of eighteen months. Outcome of the subscription: The minimum amount equivalent to 25% (twenty five percent) of the Issue Price of the Convertible Warrants shall be paid at the time of subscription and allotment of each Convertible Warrant and the balance payment equivalent to 75% (seventy five percent) of the Issue Price of the Convertible Warrants on or before the exercise of the right attached to the Convertible Warrants, to convert the Convertible Warrants and subscribe to equity shares of the Company within a period of 18 (Eighteen) months from allotment of Convertible Warrants. Issue Price: Issue Price is Rs. 176.10/- per Convertible Warrant, the price is determined in terms of ICDR Regulations. Number of investors/allotees: 4 iii. in case of convertibles Each Convertible Warrant is convertible into equal number of - intimation on equity shares in one or more tranches within a period of eighteen conversion of months from the date of allotment of the Convertible Warrants. securities or on lapse of the tenure of the The Company shall intimate the stock exchange as and when instrument; Convertible Warrants will be converted into Equity Shares. e) Any cancellation or Not Applicable termination of proposal for issuance of securities including reasons thereof. FOR SHREE HARI CHEMICALS EXPORT LIMITED BANKESH CHANDRA AGRAWAL Chairman & Managing Director DIN: 00121080 DETAILS PURSUANT TO REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 READ WITH SEBI CIRCULAR No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 DATED J [Showing first 8,000 characters — download PDF for full document]